Jeisys Medical Inc
KOSDAQ:287410
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
KR |
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
969.9B KRW | 27.7 | |
US |
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 1 085.3 | ||
US |
Abbott Laboratories
NYSE:ABT
|
187B USD | 27 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
147.4B USD | 83.4 | ||
US |
Stryker Corp
NYSE:SYK
|
131.9B USD | 40.4 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
113B USD | 48.5 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108.6B USD | 18.4 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.1B USD | 21.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
61.3B EUR | 37.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.8B USD | 56.6 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
362.5B CNY | 27.3 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.